| 000 | 00853 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517223752.0 | ||
| 264 | 0 | _c20190114 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2018.06.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStaskin, David R | |
| 245 | 0 | 0 |
_aCombination Therapy for Overactive Bladder: Who Approves? _h[electronic resource] |
| 260 |
_bEuropean urology _c10 2018 |
||
| 300 |
_a510-511 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAcetanilides |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSolifenacin Succinate |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aUrinary Bladder, Overactive |
| 773 | 0 |
_tEuropean urology _gvol. 74 _gno. 4 _gp. 510-511 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2018.06.014 _zAvailable from publisher's website |
| 999 |
_c28560994 _d28560994 |
||